Stock SLP SIMULATIONS PLUS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Simulations Plus, Inc.

Equities

SLP

US8292141053

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
44.69 USD -1.97% Intraday chart for Simulations Plus, Inc. -1.04% -0.13%
Apr. 17 InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance CI
Apr. 04 Sector Update: Health Care Stocks Slump Late Afternoon MT

Valuation

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 633.1 1,169 891.9 1,215 886.5 893.1 - -
Enterprise Value (EV) 1 633.1 1,169 891.9 1,215 886.5 893.1 893.1 893.1
P/E ratio 75.2 x 119 x 94.3 x 100 x 90.8 x 68.1 x 55.5 x -
Yield 0.66% 0.4% - - - - - -
Capitalization / Revenue 18.6 x 28.1 x 19.2 x 22.5 x 14.9 x 13.1 x 11.7 x 9.96 x
EV / Revenue 18.6 x 28.1 x 19.2 x 22.5 x 14.9 x 13.1 x 11.7 x 9.96 x
EV / EBITDA - 80.3 x 60.1 x 57.9 x 43 x 37.7 x 31.6 x -
EV / FCF - 109 x 50.7 x 71.1 x 41.4 x 93.5 x 75.7 x 58.5 x
FCF Yield - 0.91% 1.97% 1.41% 2.41% 1.07% 1.32% 1.71%
Price to Book - - - 6.83 x - - - -
Nbr of stocks (in thousands) 17,531 19,627 20,133 20,236 19,927 19,985 - -
Reference price 2 36.11 59.58 44.30 60.05 44.49 44.69 44.69 44.69
Announcement Date 11/13/19 11/16/20 10/25/21 10/26/22 10/25/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 33.97 41.59 46.47 53.91 59.58 68.07 76.17 89.68
EBITDA 1 - 14.57 14.84 21 20.6 23.68 28.23 -
EBIT 1 10.65 11.61 11.25 14.91 8.725 12.42 17.58 19.73
Operating Margin 31.35% 27.9% 24.22% 27.66% 14.64% 18.24% 23.08% 22%
Earnings before Tax (EBT) 1 10.56 11.39 11.08 15.12 11.7 17.04 21.51 -
Net income 1 8.583 9.332 9.782 12.48 9.961 13.34 16.56 -
Net margin 25.27% 22.44% 21.05% 23.16% 16.72% 19.6% 21.74% -
EPS 2 0.4800 0.5000 0.4700 0.6000 0.4900 0.6567 0.8050 -
Free Cash Flow 1 - 10.68 17.58 17.08 21.4 9.556 11.8 15.26
FCF margin - 25.68% 37.83% 31.69% 35.92% 14.04% 15.49% 17.02%
FCF Conversion (EBITDA) - 73.32% 118.41% 81.34% 103.9% 40.35% 41.81% -
FCF Conversion (Net income) - 114.45% 179.68% 136.83% 214.87% 71.63% 71.26% -
Dividend per Share 0.2400 0.2400 - - - - - -
Announcement Date 11/13/19 11/16/20 10/25/21 10/26/22 10/25/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: August 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 12.42 14.8 14.96 11.7 11.96 15.75 16.23 15.6 14.5 18.3 17.96 17.31 16.33 20.98 21.05
EBITDA 1 4.636 7.2 6.3 2.3 3 6.2 6.5 4.9 3.4 7.1 6.994 6.162 4.548 8.63 8.309
EBIT 1 3.791 5.48 4.946 0.7 0.878 4.034 4.097 -0.3 0.96 4.442 3.762 3.25 1.698 5.73 5.359
Operating Margin 30.53% 37.04% 33.06% 5.98% 7.34% 25.61% 25.24% -1.92% 6.62% 24.27% 20.95% 18.77% 10.4% 27.32% 25.45%
Earnings before Tax (EBT) 1 3.856 5.533 4.834 0.892 1.618 5.068 4.94 0.069 2.406 5.252 4.946 4.435 2.858 6.895 6.529
Net income 1 3.026 4.409 4.087 1 1.245 4.174 4.008 0.5 1.945 4.029 3.883 3.485 2.229 5.378 5.092
Net margin 24.37% 29.8% 27.32% 8.55% 10.41% 26.5% 24.69% 3.21% 13.41% 22.01% 21.62% 20.13% 13.65% 25.64% 24.19%
EPS 2 0.1500 0.2100 0.2000 0.0500 0.0600 0.2000 0.2000 0.0300 0.1000 0.2000 0.1900 0.1700 0.1100 0.2600 0.2500
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 1/6/22 4/6/22 7/6/22 10/26/22 1/4/23 4/5/23 7/6/23 10/25/23 1/3/24 4/3/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - 10.7 17.6 17.1 21.4 9.56 11.8 15.3
ROE (net income / shareholders' equity) - 9.63% 6.08% 7.26% 5.72% 22.9% - -
ROA (Net income/ Total Assets) - - - 6.63% - - - -
Assets 1 - - - 188.4 - - - -
Book Value Per Share - - - 8.800 - - - -
Cash Flow per Share - - - - - - - -
Capex 1 0.14 0.23 1.63 0.82 0.45 4 4 4.16
Capex / Sales 0.41% 0.56% 3.5% 1.52% 0.76% 5.88% 5.25% 4.64%
Announcement Date 11/13/19 11/16/20 10/25/21 10/26/22 10/25/23 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Simulations Plus, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
44.69 USD
Average target price
53.67 USD
Spread / Average Target
+20.09%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-0.13% 893M
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.36% 32.47B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+14.14% 7.45B
SECTRA AB Stock Sectra AB
+22.93% 3.89B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-16.29% 3.17B
OMNICELL, INC. Stock Omnicell, Inc.
-25.96% 1.28B
LUNIT INC. Stock Lunit Inc.
-36.14% 1.09B
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-35.42% 902M
VERADIGM INC. Stock Veradigm Inc.
-24.12% 857M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-18.47% 693M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. SLP Stock
  4. Financials Simulations Plus, Inc.